(Q52875756)
Statements
Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trial. (English)
1 reference
Matthias Mölle
1 reference
Helmut Oettle
1 reference
Hanno Riess
1 reference
Jens M Stieler
1 reference
Gerhard Heil
1 reference
Ingo Schwaner
1 reference
Jörg Seraphin
1 reference
Martin Görner
1 reference
Tim F Greten
1 reference
Volker Lakner
1 reference
Sven Bischoff
1 reference
Marianne Sinn
1 reference
Bernd Dörken
1 reference
Uwe Pelzer
1 reference
30 June 2014
1 reference
32
1 reference
23
1 reference
2423-2429
1 reference